RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Philogen SpA Stock

Philogen SpA ROCE 2025

Philogen SpA ROCE

0.27

Ticker

PHIL.MI

ISIN

IT0005373789

WKN

A2QQB6

In 2025, Philogen SpA's return on capital employed (ROCE) was 0.27, a -378.86% increase from the -0.1 ROCE in the previous year.

Philogen SpA Aktienanalyse

What does Philogen SpA do?

Philogen SpA is a biopharmaceutical company that was founded in Siena, Italy in 1996. The company's history began when a group of scientists and physicians came together to find novel solutions for combating cancer and other serious diseases. Since then, Philogen has achieved several breakthroughs in research and has become a leading company in the biotech industry. The business model of Philogen is to identify, develop and produce therapeutic antibodies and peptides to treat serious diseases such as cancer, autoimmune diseases, and inflammation. The company specializes in discovering and optimizing antibodies and peptides using advanced technologies such as phage display, ribosomal display, and lectin binding, which allow them to identify highly specific drug candidates. Philogen has several business areas including oncology, autoimmune diseases and inflammation, infectious diseases, and dermatology. In the field of oncology, the company focuses on developing its own clinical programs as well as partnerships with other pharmaceutical companies. Some of Philogen's key products include TNF receptor-based molecules that can be used to treat autoimmune diseases such as psoriasis and rheumatoid arthritis, as well as antibody candidates developed for treating various types of cancer such as breast cancer and prostate cancer. Philogen has multiple offices worldwide, including in Switzerland, Germany, the USA, and Japan, and collaborates with a variety of partners in the industry. The company also has a strong patent strategy that allows it to protect its innovation. Philogen has a total of more than 200 patents and patent applications, as well as several awards and recognitions for its research work. In summary, Philogen SpA is an innovative biopharmaceutical company dedicated to developing novel therapeutic antibodies and peptides to treat serious diseases such as cancer, autoimmune diseases, and inflammation. The company has strong research expertise and a wide range of products and services that enable it to achieve its goals. Philogen is also a key player in the industry and works with a variety of partners to maintain and expand its innovation. Philogen SpA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Philogen SpA's Return on Capital Employed (ROCE)

Philogen SpA's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Philogen SpA's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Philogen SpA's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Philogen SpA’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Philogen SpA stock

What is the ROCE (Return on Capital Employed) of Philogen SpA this year?

The ROCE of Philogen SpA is 0.27 undefined this year.

How has the ROCE (Return on Capital Employed) of Philogen SpA developed compared to the previous year?

The ROCE of Philogen SpA has increased by -378.86% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Philogen SpA?

A high Return on Capital Employed (ROCE) indicates that Philogen SpA has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Philogen SpA?

A low ROCE (Return on Capital Employed) can indicate that Philogen SpA has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Philogen SpA impact the company?

An increase in the ROCE of Philogen SpA can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Philogen SpA affect the company?

A decrease in ROCE of Philogen SpA can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Philogen SpA?

Some factors that can affect Philogen SpA's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Philogen SpA so important for investors?

The ROCE of Philogen SpA is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Philogen SpA take to improve the ROCE?

To improve the ROCE, Philogen SpA can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Philogen SpA pay?

Over the past 12 months, Philogen SpA paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Philogen SpA is expected to pay a dividend of 0 EUR.

What is the dividend yield of Philogen SpA?

The current dividend yield of Philogen SpA is .

When does Philogen SpA pay dividends?

Philogen SpA pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Philogen SpA?

Philogen SpA paid dividends every year for the past 0 years.

What is the dividend of Philogen SpA?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Philogen SpA located?

Philogen SpA is assigned to the '-' sector.

Wann musste ich die Aktien von Philogen SpA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Philogen SpA from 7/9/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/9/2025.

When did Philogen SpA pay the last dividend?

The last dividend was paid out on 7/9/2025.

What was the dividend of Philogen SpA in the year 2024?

In the year 2024, Philogen SpA distributed 0 EUR as dividends.

In which currency does Philogen SpA pay out the dividend?

The dividends of Philogen SpA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Philogen SpA

Our stock analysis for Philogen SpA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Philogen SpA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.